Sept 25 (Reuters) - ADARx Pharmaceuticals said on Thursday it had raised $446.3 million in an upsized US initial public offering, reflecting growing investor appetite for biotech listings.
ADARx Pharmaceuticals raises $446.3 million in upsized US IPO
